Canada Life
INSY

Canada Life’s Insys Therapeutics, Inc. INSY Stock Holding History

Canada Life’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,200
Closed -$15K – 2832
2019
Q1 		$15K Hold
3,200
– – ﹤0.01% 2385
2018
Q4 		$11K Hold
3,200
– – ﹤0.01% 2585
2018
Q3 		$32K Hold
3,200
– – ﹤0.01% 2470
2018
Q2 		$23K Hold
3,200
– – ﹤0.01% 2509
2018
Q1 		$19K Hold
3,200
– – ﹤0.01% 2510
2017
Q4 		$31K Hold
3,200
– – ﹤0.01% 2447
2017
Q3 		$28K Hold
3,200
– – ﹤0.01% 2453
2017
Q2 		$40K Hold
3,200
– – ﹤0.01% 2385
2017
Q1 		$33K Hold
3,200
– – ﹤0.01% 2394
2016
Q4 		$30K Hold
3,200
– – ﹤0.01% 2435
2016
Q3 		$38K Hold
3,200
– – ﹤0.01% 2386
2016
Q2 		$41K Hold
3,200
– – ﹤0.01% 2356
2016
Q1 		$51K Hold
3,200
– – ﹤0.01% 2120
2015
Q4 		$92K Hold
3,200
– – ﹤0.01% 1822
2015
Q3 		$91K Sell
3,200
-318
-9% -$11.7K ﹤0.01% 1769
2015
Q2 		$126K Sell
3,518
-16
-0.5% -$498 ﹤0.01% 1698
2015
Q1 		$102K Buy
3,534
+3,200
+958% +$84.6K ﹤0.01% 1781
2014
Q4 		$7K Buy
+334
New +$6.61K ﹤0.01% 2454

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Canada Life's INSY Position: Q2 2019 in Review

Canada Life sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 3,200 shares — an estimated $15K sold.

Canada Life first reported a position in INSY in Q4 2014 and held it in 18 quarters. The position peaked at $126K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Canada Life reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Canada Life sold 3,200 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $15K.
  • Canada Life first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 18 quarters.
  • Canada Life's Insys Therapeutics, Inc. position peaked at $126K in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Canada Life's 13F filing for Q2 2019, filed 31 Jul 2019.